Stay updated on Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.

Latest updates to the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedFooter revision label updated from Revision: v3.6.5 to Revision: v3.6.6, representing a minor page update. It does not indicate changes to the study content or data.SummaryDifference0.1%

- Check19 days agoChange DetectedAn entry '2017 ( U.S. NIH Grant/Contract )' was added to the study's identifiers/funding area, appearing alongside the GISG and EudraCT numbers. This enriches the record with NIH funding attribution for that year.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a platform version update on the page.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page shows a new revision label (v3.6.4) replacing the previous v3.6.3, indicating a software update to the page. The change does not modify study content or essential outcomes.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision indicator updated from v3.6.0 to v3.6.3 in the page footer, reflecting a software update to the site interface rather than any change to study content.SummaryDifference0.0%

- Check90 days agoChange DetectedNew user-help sections were added to the page (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated Intervention/Treatment area and a Revision: v3.6.0 tag; the older 'Intervention / Treatment' label was replaced with 'Intervention/Treatment', the revision history updated from v3.5.5 to v3.6.0, and a 'No longer looking for participants' notice was added to indicate enrollment is closed.SummaryDifference0.4%

Stay in the know with updates to Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.